These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11586113)

  • 1. Clinical and electroencephalographic effects of topiramate in patients with epilepsy and healthy volunteers.
    Mecarelli O; Piacenti A; Pulitano P; Vicenzini E; Rizzo C; Rinalduzzi S; de Feo MR; Accornero N
    Clin Neuropharmacol; 2001; 24(5):284-9. PubMed ID: 11586113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacological and clinical review on topiramate, a new antiepileptic drug.
    Perucca E
    Pharmacol Res; 1997 Apr; 35(4):241-56. PubMed ID: 9264038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of vigabatrin, lamotrigine, and topiramate on quantitative EEGs in patients with epilepsy.
    Neufeld MY; Kogan E; Chistik V; Korczyn AD
    Clin Neuropharmacol; 1999; 22(2):80-6. PubMed ID: 10202602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy.
    Langtry HD; Gillis JC; Davis R
    Drugs; 1997 Nov; 54(5):752-73. PubMed ID: 9360061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative EEG effects of topiramate.
    Wang WW; Li JC; Wu X
    Clin Electroencephalogr; 2003 Apr; 34(2):87-92. PubMed ID: 12784907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate: a review of its use in the treatment of epilepsy.
    Lyseng-Williamson KA; Yang LP
    Drugs; 2007; 67(15):2231-56. PubMed ID: 17927286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate: a new antiepileptic drug.
    Privitera MD
    Ann Pharmacother; 1997 Oct; 31(10):1164-73. PubMed ID: 9337443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate: a new antiepileptic drug for refractory epilepsy.
    Walker MC; Sander JW
    Seizure; 1996 Sep; 5(3):199-203. PubMed ID: 8902921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate and word-finding difficulties in patients with epilepsy.
    Mula M; Trimble MR; Thompson P; Sander JW
    Neurology; 2003 Apr; 60(7):1104-7. PubMed ID: 12682314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate titration to response: analysis of individualized therapy study (TRAITS).
    Dodson WE; Kamin M; Kraut L; Olson WH; Wu SC
    Ann Pharmacother; 2003 May; 37(5):615-20. PubMed ID: 12708932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities.
    Singh BK; White-Scott S
    Seizure; 2002 Jan; 11(1):47-50. PubMed ID: 11888260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.
    Grosso S; Franzoni E; Iannetti P; Incorpora G; Cardinali C; Toldo I; Verrotti A; Caterina Moscano F; Lo Faro V; Mazzone L; Zamponi N; Boniver C; Spalice A; Parisi P; Morgese G; Balestri P
    J Child Neurol; 2005 Nov; 20(11):893-7. PubMed ID: 16417859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
    Clark AM; Kriel RL; Leppik IE; White JR; Henry TR; Brundage RC; Cloyd JC
    Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.
    Gilliam FG; Veloso F; Bomhof MA; Gazda SK; Biton V; Ter Bruggen JP; Neto W; Bailey C; Pledger G; Wu SC
    Neurology; 2003 Jan; 60(2):196-202. PubMed ID: 12552030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate: effect on EEG interictal abnormalities and background activity in patients affected by focal epilepsy.
    Placidi F; Tombini M; Romigi A; Bianchi L; Izzi F; Sperli F; Mattia D; Cervellino A; Marciani MG
    Epilepsy Res; 2004 Jan; 58(1):43-52. PubMed ID: 15066674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cotherapy reduction on tolerability of epilepsy add-on therapy: a randomized controlled trial.
    Naritoku DK; Hulihan JF; Schwarzman LK; Kamin M; Olson WH
    Ann Pharmacother; 2005 Mar; 39(3):418-23. PubMed ID: 15701778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.
    Blum D; Meador K; Biton V; Fakhoury T; Shneker B; Chung S; Mills K; Hammer A; Isojärvi J
    Neurology; 2006 Aug; 67(3):400-6. PubMed ID: 16894098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Topiramate--a new antiepileptic agents].
    Svendsen T; Johannessen SI; Nakken KO
    Tidsskr Nor Laegeforen; 2000 May; 120(13):1536-8. PubMed ID: 10916475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of topiramate for the treatment of epilepsy in elderly patients.
    Sommer BR; Fenn HH
    Clin Interv Aging; 2010 Apr; 5():89-99. PubMed ID: 20458347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.